Collaborating in new research project, from the left: Professor Ola Myklebost, leader for NCGC and the research project, Dr. Richard Stratford, CEO of OncoImmunity, Professor Eivind Hovig, Institute for Cancer Research at Oslo University Hospital and Dr. Trevor Clancy, CSO at OncoImmunity.

Immunotherapy: Finding the Right Fit

A new Norwegian research collaboration helps uncover what treatments are the right fit for American cancer patients.